Masimo Partners with Google to Develop a Reference Platform That Helps Device Manufacturers Bring High-performing Wear OS Smartwatches to Market
Masimo announced a partnership with Google to develop a comprehensive smartwatch reference platform for OEMs building Wear OS ...
Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers
Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by ...
Joplin Globe4d
Masimo Shares Final Thoughts Ahead of September 19 Annual Meeting Where Everything is at Stake
Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...
Zacks.com on MSN2d
Masimo's Stock Up Following the New Tie-Up With Google to Boost Wear OS
MASI's latest partnership is likely to develop a new reference platform that brings high-performing Wear OS smartwatches to market.
Nasdaq2d
Masimo's Stock Up Following the New Tie-Up With Google to Boost Wear OS
The latest partnership is expected to significantly strengthen Masimo’s patient monitoring business ... Center would be adopting the use of its SafetyNet cloud-based telemonitoring platform ...
MassDevice20h
Masimo CEO Joe Kiani faces shareholder vote today
Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...
Business Wire6d
Masimo Issues Statement Following Court’s Order Holding Politan and Quentin Koffey in Contempt and Finding Politan Made False Statements to Stockholders
Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today issued ...
Stockhouse4d
Masimo Shares Final Thoughts Ahead of September 19 Annual Meeting Where Everything is at Stake
“For more than 35 years, the team at Masimo has poured our heart and soul into driving innovations for patients and value for stockholders. We have internalized our stockholders’ ...